145 related articles for article (PubMed ID: 32662710)
1. Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6C
Chen Y; Zhang H; Hu L; Shi H; Liu X; Jia J; Sun S; Ou Y; Luo X; Zhou G; Shen W
J Int Med Res; 2020 Jul; 48(7):300060520932816. PubMed ID: 32662710
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
Zhang X; Xiao S; Li Q
J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12.
Wang HM; Gao JH; Lu JL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4995-5003. PubMed ID: 30070336
[TBL] [Abstract][Full Text] [Related]
4. E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction.
Dutta P; Hoyer FF; Sun Y; Iwamoto Y; Tricot B; Weissleder R; Magnani JL; Swirski FK; Nahrendorf M
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1802-8. PubMed ID: 27470513
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin attenuates interferon-gamma action via modulation of STAT1 to prevent aortic atherosclerosis in apolipoprotein E-knockout mice.
Zhou XX; Gao PJ; Sun BG
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):373-9. PubMed ID: 19018808
[TBL] [Abstract][Full Text] [Related]
6. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
Woo JM; Lin Z; Navab M; Van Dyck C; Trejo-Lopez Y; Woo KM; Li H; Castellani LW; Wang X; Iikuni N; Rullo OJ; Wu H; La Cava A; Fogelman AM; Lusis AJ; Tsao BP
Arthritis Res Ther; 2010; 12(3):R93. PubMed ID: 20482780
[TBL] [Abstract][Full Text] [Related]
7. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
8. StemBell therapy stabilizes atherosclerotic plaques after myocardial infarction.
Woudstra L; Meinster E; VAN Haren L; Kay AM; Koopman M; Belien JAM; Morrison MC; VAN Rossum AC; Helder MN; Juffermans LJM; Niessen HWM; Krijnen PAJ
Cytotherapy; 2018 Sep; 20(9):1143-1154. PubMed ID: 30107976
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway.
Yan W; Li D; Zhou X
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):344-352. PubMed ID: 27998006
[TBL] [Abstract][Full Text] [Related]
10. The Dynamics of Circulating Monocyte Subsets and Intra-Plaque Proliferating Macrophages during the Development of Atherosclerosis in ApoE
Liu JX; Li X; Ji WJ; Yan LF; Li T; Li YX; Xu ZW; Yang GH; Li YM; Zhao JH; Zhou X
Int Heart J; 2019 May; 60(3):746-755. PubMed ID: 31019169
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
13. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
15. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
[TBL] [Abstract][Full Text] [Related]
16. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
[TBL] [Abstract][Full Text] [Related]
17. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis.
Panizzi P; Swirski FK; Figueiredo JL; Waterman P; Sosnovik DE; Aikawa E; Libby P; Pittet M; Weissleder R; Nahrendorf M
J Am Coll Cardiol; 2010 Apr; 55(15):1629-38. PubMed ID: 20378083
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice.
Park KY; Oh E; Kwak MK; Jun HS; Heo TH
PLoS One; 2016; 11(3):e0150791. PubMed ID: 26950217
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
